16.4 mn people in Maha yet to take 2nd dose of Covid vaccines: Health dept

16.4 million people in Maharashtra are yet to take the second dose of coronavirus vaccines and the state health department is pursuing them to get jabbed at the earliest

Topics
Coronavirus Vaccine | India vaccination | Maharashtra

Press Trust of India  |  Mumbai 

Nearly 1.64 crore people in are yet to take the second dose of coronavirus vaccines and the state health department is pursuing them to get jabbed at the earliest to complete the two-shot course and ensure protection against COVID-19, a senior official said on Friday.

From December to mid-January, the state administered was administering eight to nine lakh vaccine doses daily, but the number has dropped significantly now, Dr Sachin Desai, in-charge of the state's immunisation programme, said.

Now, the number has dropped to 2 to 2.5 lakh doses a day. There are nearly 1.64 crore people who have missed their second dose, Desai told PTI.

Of the 1.64 crore people who have to take their second dose, 1.30 are those who have been administered Covishield, while the rest are Covaxin recipients, he said.

Desai said Nanded, Dhule, Nandurbar and Beed districts have recorded an immunisation percentage of 65 for the first dose as against the state average of 92-93 per cent.

For the second dose, these districts have recorded an immunisation percentage of 65, while the state's average is 72-73 per cent, he said.

Desai said the state has been undertaking different mass campaigns like 'Kawach Kundal' and 'Har Ghar Dastak' to improve inoculation coverage against COVID-19 whose third wave has now ebbed across the country.

According to state Health Department data available till March 10, has administered 15,73,09,386 vaccine doses so far.

In the age group of 15-18 years, which was added to the inoculation drive in January, 36,57,816 youngsters have been administered the first dose and 21,56,468 the second shot (this age bracket is administered only Covaxin), the data showed.

In the age group of 18-44 years, 4,87,80,677 beneficiaries have been administered the first dose, while 3,68,17,881 have received the second dose as well.

In the age bracket of 45-59 years, 1,83,26,040 people have been administered the first dose and 1,52,72,113 the second dose. In the age group of 60 years and above, 1,32,98,789 have been administered the first dose, 1,07,72,383 the second shot, while 9,72,107 people have received the precaution dose too, according to the data.

In the healthcare worker category, 12,95,132 have been administered the first dose, 11,85,590 the second shot, while 3,08,777 have received the third (or booster) dose also.

With regards to frontline Workers, 21,49,282 have received the first dose, 19,90,837 the second dose and 3,25,494 the precaution dose, the data showed.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Fri, March 11 2022. 17:06 IST
RECOMMENDED FOR YOU